Mounjaro NHS Prescription UK: Eligibility & Access 2025

Clinically Proven UK Registered Pharmacy

UK-Specific Mounjaro NHS Access Information

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £10 off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£145.00 From £135.00 £10 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £135.00

£36.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £169.00

£44.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £210.00

£55.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £235.00

£61.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £260.00

£67.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £277.00

£71.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £79.00

£22.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £99.00

£27.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £109.00

£29.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £159.00

£42.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £189.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation

UK-Specific Mounjaro NHS Access Information

Understanding mounjaro nhs prescription uk eligibility can be complex, as access through the NHS remains restricted to specific clinical pathways in 2025. While NICE has approved tirzepatide for type 2 diabetes management, routine NHS prescription for weight management alone faces significant limitations due to budget constraints and strict eligibility criteria established by local integrated care boards.

Current NHS Mounjaro Eligibility Criteria in the UK

As of 2025, Mounjaro (tirzepatide) is licensed by the MHRA for both type 2 diabetes and weight management in the UK, but NHS availability differs substantially between these indications [1]. For type 2 diabetes, NICE technology appraisal TA924 recommends tirzepatide as a treatment option when specific glycaemic control targets are not met with other therapies. However, for weight management in patients without diabetes, NHS access remains severely restricted.

Most integrated care boards across England, Scotland, Wales, and Northern Ireland have not commissioned Mounjaro for routine weight management due to budget pressures and prioritisation decisions. Where NHS prescription is theoretically available for weight management, patients typically must meet a BMI threshold of 35 kg/m² or above (or 32.5 kg/m² for patients from South Asian, Chinese, or Black African backgrounds) with at least one weight-related comorbidity, and have documented evidence of previous supervised weight loss attempts [2].

Even when eligibility criteria are met, significant waiting lists exist at specialist weight management services, with some patients reporting waits exceeding 12-18 months for initial assessment. Your GP can refer you to a tier 3 weight management service, but cannot typically initiate Mounjaro prescription directly for weight management outside of these specialist pathways.

Why NHS Access to Mounjaro Remains Limited

The primary barrier to widespread NHS mounjaro prescription availability is financial rather than clinical. NHS England has not yet negotiated a population-level agreement with Eli Lilly for weight management indications, unlike some arrangements for diabetes medications. Budget impact analyses suggest that unrestricted NHS provision of GLP-1 receptor agonists for weight management could cost billions annually, exceeding current allocations for obesity services.

Additionally, NHS clinical guidelines emphasise a stepped care approach to weight management, requiring patients to complete structured lifestyle programmes, dietary interventions, and potentially older medications like orlistat before consideration of newer injectable therapies. This staged approach, whilst evidence-based in principle, creates practical delays for patients seeking access to the most effective treatments demonstrated in clinical trials.

Regional Variation Across UK Health Systems

Mounjaro NHS prescription policies vary considerably across the UK's devolved health systems. NHS Scotland, NHS Wales, and Health and Social Care Northern Ireland each operate independent formulary and commissioning decisions. Some Scottish health boards have piloted specialist weight management clinics with access to tirzepatide, whilst others maintain restrictive policies. Patients should contact their local integrated care board or health board directly to understand specific regional policies and waiting times.

Private Prescription Pathways for Mounjaro in the UK

For patients who do not meet NHS mounjaro eligibility criteria or face prohibitive waiting times, private prescription through UK-registered pharmacies offers a legitimate alternative route. At Cured Pharmacy, Mounjaro is available from £135.00 following a free online consultation with a UK-registered prescriber, typically completed in under three minutes. All prescriptions are issued by GMC-registered doctors or independent prescribers working within MHRA and GPhC regulatory frameworks.

Private prescription eligibility criteria differ from NHS thresholds. UK prescribers assess suitability based on BMI (typically 30 kg/m² or above, or 27 kg/m² with weight-related comorbidities), medical history, current medications, and contraindications. The clinical assessment ensures tirzepatide is appropriate and safe for your individual circumstances, with ongoing monitoring recommendations provided.

Choosing private prescription eliminates waiting lists and provides access to transparent upfront pricing. Cured Pharmacy guarantees the lowest prices in the UK for genuine, UK-licensed Mounjaro KwikPens, with discreet packaging and delivery directly to your address. Prescriptions are valid for repeat supplies subject to ongoing clinical review, allowing continuity of treatment without repeated GP appointments.

Access Route Typical Waiting Time Eligibility Criteria Cost
NHS Specialist Service 12-18 months BMI ≥35 (or ≥32.5 for certain ethnicities), documented lifestyle attempts, specialist referral £9.90 per item (England) or free
Private Online Pharmacy 24-48 hours BMI ≥30 (or ≥27 with comorbidities), medical history assessment From £145.00 per month
Private Weight Loss Clinic 1-4 weeks Varies by clinic, typically BMI ≥30 £200-350 per month plus consultation fees

How Mounjaro Compares to Other Weight Loss Treatments

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK, offering a distinct mechanism compared to single-pathway GLP-1 agonists like semaglutide (Wegovy) or liraglutide (Saxenda) [3]. By activating both glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptors, tirzepatide produces enhanced effects on appetite regulation, insulin secretion, and energy expenditure.

Clinical trial data demonstrates superior weight loss outcomes with tirzepatide compared to semaglutide. In the SURPASS-2 head-to-head trial, patients receiving tirzepatide 15mg achieved average weight reductions of 12.4kg compared to 6.2kg with semaglutide 1mg over 40 weeks [1]. The SURMOUNT-1 trial showed average body weight reductions of up to 22.5% with the highest tirzepatide dose over 72 weeks in patients without diabetes [3].

Wegovy (semaglutide) and Saxenda (liraglutide) remain effective alternatives with their own evidence base. Wegovy demonstrated average weight loss of 14.9% in the STEP-1 trial, whilst Saxenda (requiring daily rather than weekly injection) showed average reductions of 8% in the SCALE trials [4]. Your UK prescriber will recommend the most appropriate treatment based on your clinical profile, preferences regarding injection frequency, and cost considerations.

Oral Alternatives and Non-Injectable Options

For patients preferring non-injectable treatments, orlistat remains the primary oral medication licensed for weight management in the UK. Available as prescription-strength Xenical 120mg or lower-dose Alli 60mg, orlistat works by reducing dietary fat absorption rather than affecting appetite hormones. Whilst less effective than GLP-1 therapies in clinical trials (average 3-5% weight loss), orlistat may suit patients with needle phobia or specific contraindications to injectable treatments. Cured Pharmacy offers orlistat from £135.00 following online consultation.

Starting Mounjaro: Dosing, Titration, and What to Expect

Mounjaro treatment follows a structured dose escalation schedule to minimise gastrointestinal side effects whilst optimising efficacy. All patients begin with the 2.5mg once-weekly injection for four weeks, regardless of body weight or previous treatment history. This starter dose allows your body to adapt to the medication's effects on gastric emptying and appetite signalling.

After the initial four weeks, the dose increases to 5mg weekly for another four weeks, then typically progresses to 7.5mg, 10mg, 12.5mg, or the maximum 15mg dose based on your response and tolerability [1]. Your UK prescriber will provide a personalised titration schedule and review your progress at regular intervals. Most patients reach their maintenance dose within 20-24 weeks of starting treatment.

Common side effects during the escalation phase include nausea, reduced appetite, occasional vomiting, and changes in bowel habits. These effects are generally mild to moderate and diminish as your body adjusts to each dose level. Staying well hydrated, eating smaller portions, and avoiding high-fat meals can help manage initial gastrointestinal symptoms. Serious side effects are rare but include pancreatitis, gallbladder problems, and severe allergic reactions — your prescriber will discuss warning signs during your consultation.

Injection Technique and Storage Requirements

Mounjaro KwikPens are pre-filled, single-use devices designed for subcutaneous injection into the abdomen, thigh, or upper arm. Each pen contains four doses and should be stored in the refrigerator between 2-8°C until first use. Once in use, pens may be kept at room temperature (up to 30°C) for up to 21 days. Your pharmacist will provide detailed injection instructions, and demonstration videos are available through the manufacturer's patient support programme.

Cost Comparison: NHS Versus Private Mounjaro Prescription

For the minority of patients who successfully access Mounjaro through NHS prescription, the cost is limited to standard prescription charges (currently £135.00 per item in England, free in Scotland, Wales, and Northern Ireland, or covered by prepayment certificates). However, the practical barriers — including specialist referral requirements, 12-18 month waiting lists, and restrictive eligibility criteria — mean most UK patients seeking tirzepatide for weight management must pursue private prescription routes.

Private prescription costs vary across UK pharmacies, but Cured Pharmacy offers the lowest guaranteed prices at £135.00 per four-week supply for starter doses. Higher maintenance doses are priced proportionally, with transparent costs displayed before you complete your clinical consultation. Unlike some providers, there are no hidden fees, subscription charges, or mandatory add-on services — you pay only for the medication and clinical assessment.

When comparing total cost of access, private prescription may prove more cost-effective than NHS routes when factoring in the opportunity cost of delayed treatment. Clinical evidence shows that earlier intervention produces better long-term outcomes, and the metabolic benefits of significant weight loss — including reduced cardiovascular risk and improved glycaemic control — may offset medication costs through reduced need for other treatments [2]. Your prescriber can discuss the cost-benefit considerations specific to your clinical situation.

Scientific References

  1. Frias, J. P., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes (SURPASS-2): a randomised, open-label, parallel-group, multicentre, phase 3 trial. The Lancet, 398(10295), 64-77. https://doi.org/10.1016/S0140-6736(21)01324-6
  2. National Institute for Health and Care Excellence. (2023). Tirzepatide for treating type 2 diabetes [TA924]. NICE. https://www.nice.org.uk/guidance/ta924
  3. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. https://doi.org/10.1056/NEJMoa2206038
  4. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Mounjaro is a prescription-only medicine that must be prescribed by a GMC-registered doctor or independent prescriber following appropriate clinical evaluation.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

Can I get Mounjaro on the NHS for weight loss?
NHS access to Mounjaro for weight management remains very limited in 2025, with most integrated care boards not commissioning it routinely due to budget constraints. Patients typically need BMI ≥35 with comorbidities and must be referred to specialist weight management services with significant waiting lists.
What is the mounjaro nhs prescription uk eligibility criteria?
For weight management, NHS eligibility typically requires BMI ≥35 kg/m² (or ≥32.5 kg/m² for certain ethnic groups), at least one weight-related comorbidity, documented evidence of supervised lifestyle interventions, and specialist service referral. Criteria vary by region and many areas have not commissioned the treatment.
How long is the NHS waiting list for Mounjaro?
Waiting times for NHS specialist weight management services where Mounjaro may be available range from 12-18 months or longer in many areas. Some regions have no commissioned services for tirzepatide weight management, meaning NHS access is effectively unavailable regardless of eligibility.
Is private Mounjaro prescription legal in the UK?
Yes, private prescription of Mounjaro is entirely legal and regulated by the MHRA and GPhC. UK-registered prescribers can issue private prescriptions following appropriate clinical assessment, and registered pharmacies like Cured Pharmacy dispense genuine UK-licensed medication in compliance with all regulatory requirements.
How much does Mounjaro cost privately in the UK?
Private Mounjaro prescription costs vary across providers, with Cured Pharmacy offering the lowest UK prices from £135.00 per four-week supply. This includes free clinical consultation with a UK prescriber and discreet delivery, with no hidden fees or subscription charges.
Can my GP prescribe Mounjaro for weight loss?
Most GPs cannot initiate Mounjaro prescription for weight management due to local commissioning restrictions and formulary limitations. Weight management prescribing of tirzepatide is typically restricted to specialist services, though your GP can refer you to these services if available in your area.
What BMI do I need for private Mounjaro prescription?
Private prescribers typically require BMI ≥30 kg/m², or ≥27 kg/m² if you have weight-related health conditions such as type 2 diabetes, hypertension, or sleep apnoea. Your UK prescriber will assess your individual suitability during the clinical consultation.
Is Mounjaro better than Wegovy for weight loss?
Clinical trial data shows tirzepatide (Mounjaro) produces greater average weight loss than semaglutide (Wegovy), with head-to-head studies demonstrating approximately double the weight reduction. However, individual response varies, and your UK prescriber will recommend the most appropriate treatment based on your medical history, preferences, and tolerability.